Erectile Dysfunction Drugs Market By Product (Viagra, Cialis, Levitra/Staxyn, Stendra/Spedra, Zydena), Route Of Administration (Oral, Injectable), & Region For 2024-2031
Report ID: 180105|No. of Pages: 202
Erectile Dysfunction Drugs Market By Product (Viagra, Cialis, Levitra/Staxyn, Stendra/Spedra, Zydena), Route Of Administration (Oral, Injectable), & Region For 2024-2031
Erectile Dysfunction Drugs Market Valuation – 2024-2031
The increased prevalence of erectile dysfunction, an aging population, and greater healthcare access in emerging nations are all driving forces in the erectile dysfunction (ED) drugs market. According to the analyst from Verified Market Research, the Erectile Dysfunction Drugs Market is estimated to reach a valuation of USD 1766.3 Million over the forecast subjugating around USD 2329.41 Million valued in 2023.
Furthermore, the growing acceptance of ED as a treatable condition is a major driver of the Erectile Dysfunction Drugs Market. It enables the market to grow at a CAGR of -3.4% from 2024 to 2031.
>>> Get | Download Sample Report @ –https://www.verifiedmarketresearch.com/download-sample/?rid=180105
Erectile Dysfunction Drugs Market: Definition/ Overview
Erectile Dysfunction (ED) drugs are pharmaceutical treatments that help men obtain and maintain an adequate erection for sexual activity. These drugs work primarily as phosphodiesterase type 5 (PDE5) inhibitors, which increase blood flow to the penis during sexual stimulation, allowing for an erection. ED drugs are commonly used to treat erectile dysfunction caused by a variety of circumstances, including age, health disorders (such as diabetes and cardiovascular disease), psychological issues, and lifestyle choices. While these drugs efficiently treat the symptoms of ED, they do not heal the underlying causes or increase sexual desire.
What's inside a VMR
industry report?
Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.
>> Ask For Discount @ – https://www.verifiedmarketresearch.com/ask-for-discount/?rid=180105
What are the Factors that Surge the Demand for Erectile Dysfunction Drugs?
The increased global incidence of erectile dysfunction (ED) is a major driver of the ED drugs market. The National Institutes of Health (NIH) estimates that over 30 million men in the United States suffer from erectile dysfunction. According to the Massachusetts Male Aging Study, around 52% of men suffer from erectile dysfunction, with the prevalence rising from 40% at age 40 to 70% at age 70. This high prevalence generates a sizable market for ED drugs.
The global aging population contributes significantly to the growth of the Erectile Dysfunction Drugs Market. According to the World Health Organization (WHO), the share of the world’s population aged 60 and more will nearly double between 2015 and 2050, from 12% to 22%. By 2030, one in every six persons in the world will be 60 or older. Because ED is more common in older persons, this demographic shift is expected to boost demand for ED drugs.
Furthermore, increased awareness of ED and its therapies, combined with less societal stigma, is propelling market expansion. The National Health Service (NHS) in the United Kingdom recorded a 4% increase in ED prescriptions between 2017 and 2018, with more than 4 million prescriptions issued in England alone. This trend suggests growing awareness and willingness to seek treatment for ED, contributing to market expansion.
What Factors Hinder the Growth of the Erectile Dysfunction Drugs Market?
Despite increased knowledge, the social stigma associated with erectile dysfunction remains a significant obstacle to market expansion. Many people are embarrassed or humiliated to acknowledge their ailment or seek treatment, seeing it as a personal failure. This hesitation resulted in the underreporting of the disease and a large number of untreated cases, reducing the potential customer base for erectile dysfunction drugs and hampering overall market growth.
Furthermore, many users, particularly those in underdeveloped countries, struggle to pay the exorbitant prices associated with branded erectile dysfunction medications. While generic alternatives exist, the upfront cost of treatment discourages many from getting help. This financial barrier prevents a broader percentage of the population from accessing effective erectile dysfunction treatment, restricting market growth potential.
Category-Wise Acumens
How Does the Viagra Propel the Growth of the ED Drugs Market?
According to VMR Analysis, the Viagra segment is estimated to hold the largest market share during the forecast period. Viagra has been a household name since its launch, due to significant marketing and favorable patient experiences. This significant brand recognition builds customer trust, making it the preferred choice for men seeking erectile dysfunction medication, consolidating its market position.
Viagra’s efficacy in treating erectile dysfunction is widely documented, with a track record of success. Its positive safety profile, which includes fewer side effects than certain alternatives, makes it appealing to both patients and healthcare practitioners. This dependability contributes greatly to its continued market dominance.
Furthermore, Viagra is widely available in a variety of forms, including generic versions, making it more accessible to customers. Its availability in retail pharmacies and online platforms provides handy purchase choices, making it easier for people to obtain medication discreetly. This widespread availability supports its dominant market position in the Erectile Dysfunction Drugs Market.
How Does the Oral Route of Administration Propel the Demand in the Market?
The oral segment is estimated to dominate the Erectile Dysfunction Drugs Market during the forecast period. Oral drugs are preferred due to their convenience and simplicity. Patients can just take a tablet before sexual activity, eliminating the need for injections or complicated procedures. This non-invasive procedure appeals to many men, making it a popular alternative for treating erectile dysfunction and contributing to its market dominance.
Many oral ED drugs, such as sildenafil and tadalafil, have a quick onset effect, usually beginning to function within 30 minutes to an hour. This short response time enables users to participate in sexual activity spontaneously, increasing user pleasure and treatment adherence, further solidifying the oral segment’s market leadership.
Furthermore, the long-standing use of oral ED drugs has increased public knowledge and acceptability. Medications like Viagra have become household brands, instilling trust in customers. This familiarity motivates more people to seek therapy for erectile dysfunction, which drives the growth of the oral administration segment in the market.
Gain Access into Erectile Dysfunction Drugs Market Report Methodology
https://www.verifiedmarketresearch.com/select-licence/?rid=180105
Country/Region-wise Acumens
How Does the High Prevalence of Aging Population Influencing Market in North America?
According to VMR Analyst, North America is estimated to dominate the Erectile Dysfunction Drugs Market during the forecast period. North America, especially the United States, has a sizable elderly population predisposed to erectile dysfunction. According to the United States Census Bureau, the number of Americans aged 65 and up is expected to nearly double, from 52 million in 2018 to 95 million by 2060. According to the Johns Hopkins Bloomberg School of Public Health, the prevalence of ED in the United States is around 18 million men, with rates rising from 5% among men aged 40 to 15% among those 70 and older. This vast and expanding populace has a substantial impact on regional demand for ED drugs.
Furthermore, North America has a high incidence of chronic disorders that are risk factors for erectile dysfunction. According to the Centers for Disease Control and Prevention (CDC), 34.2 million Americans, or 10.5% of the population, have diabetes, which is significantly connected to erectile dysfunction. Also, the American Heart Association reports that nearly half of all U.S. adults (121.5 million in 2016) had some sort of cardiovascular disease, which is another substantial risk factor for ED. These high comorbidity rates have a significant impact on the ED drugs market in North America.
What Factors Contribute to the Potential Opportunities in the Asia Pacific Region?
The Asia Pacific region is estimated to exhibit the highest growth within the Erectile Dysfunction Drugs Market during the forecast period. The Asia-Pacific region is experiencing an alarming rise in chronic diseases that are risk factors for erectile dysfunction. According to the International Diabetes Federation (IDF), the number of adults living with diabetes in the Western Pacific region (which includes much of Asia) is anticipated to rise from 163 million in 2019 to 212 million by 2045. Also, the World Health Organization (WHO) reports that cardiovascular disorders account for 35% of all deaths in the South-East Asia region. The rising prevalence of diabetes and cardiovascular disease, both major risk factors for ED, is propelling the region’s ED drug market forward.
Furthermore, many Asia Pacific countries are experiencing significant economic expansion, which has resulted in higher healthcare spending and better availability of medical treatments, including ED drugs. According to the World Bank, health expenditure per capita in East Asia and the Pacific rose from $571 in 2010 to $937 in 2018. In China, the National Health Commission announced that overall health expenditure reached 6.52 trillion yuan (approximately $1 trillion) in 2019, accounting for 6.6% of GDP. This increased investment in healthcare is enhancing access to ED treatments while also driving regional market growth.
Competitive Landscape
The competitive landscape of the Erectile Dysfunction Drugs Market is highly fragmented, with multiple firms actively competing for market share. This dynamic environment is fueled by the rising prevalence of erectile dysfunction, which is impacted by variables such as sedentary lifestyles and chronic health issues.
Some of the prominent players operating in the Erectile Dysfunction Drugs Market include:
Apricus Biosciences, Inc., Bayer AG, Eli Lilly and Company, Ferring Pharmaceuticals, GlaxoSmithKline PLC, Metuchen Pharmaceuticals LLC, Pfizer Inc., K. Chemicals Co. Ltd, Teva Pharmaceutical Industries Ltd, VIVUS Inc.
Latest Developments
- In June 2020, Launch Medical and GAINSWave announced the resolution of their lawsuit. They started working together to market their revolutionary home-use acoustic wave device called The Phoenix to treat erectile dysfunction.
- In December 2020, Glenmark Pharma received the final approval from the US health regulator for Tadalafil tablets, used to treat erectile dysfunction and enlarged prostate.
Report Scope
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2020-2031 |
| Growth Rate | CAGR of~-3.4% from 2024 to 2031 |
| Base Year for Valuation | 2023 |
| Historical Period | 2020-2022 |
| Forecast Period | 2024-2031 |
| Quantitative Units | Value in USD Million |
| Report Coverage | Historical and Forecast Revenue Forecast, Historical and Forecast Volume, Growth Factors, Trends, Competitive Landscape, Key Players, Segmentation Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Players | Apricus Biosciences, Inc., Bayer AG, Eli Lilly and Company, Ferring Pharmaceuticals, GlaxoSmithKline PLC, Metuchen Pharmaceuticals LLC, Pfizer Inc., K. Chemicals Co. Ltd, Teva Pharmaceutical Industries Ltd, VIVUS Inc. |
| Customization | Report customization along with purchase available upon request |
Erectile Dysfunction Drugs Market, By Category
Product:
- Viagra
- Cialis
- Levitra/Staxyn
- Stendra/Spedra
- Zydena
- Others
Route of Administration:
- Oral
- Injectable
Region:
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Research Methodology of Verified Market Research:
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our Sales Team at Verified Market Research.
Reasons to Purchase this Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Customization of the Report
• In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.
Frequently Asked Questions
1 INTRODUCTION OF GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET, BY PRODUCT
5.1 Viagra
5.2 Cialis
5.3 Levitra/Staxyn
5.4 Stendra/Spedra
5.5 Zydena
5.6 Others
6 GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET, BY ROUTE OF ADMINISTRATION
6.1 Overview
6.2 Oral
6.3 Injectable
7 GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET, BY GEOGRAPHY
7.1 Overview
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 U.K.
7.3.3 France
7.3.4 Rest of Europe
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Rest of Asia Pacific
7.5 Rest of the World
7.5.1 Latin America
7.5.2 Middle East and Africa
8 GLOBAL ERECTILE DYSFUNCTION DRUGS MARKET COMPETITIVE LANDSCAPE
8.1 Overview
8.2 Company Market Ranking
8.3 Key Development Strategies
9 COMPANY PROFILES
9.1 Apricus Biosciences Inc.
9.1.1 Overview
9.1.2 Financial Performance
9.1.3 Product Outlook
9.1.4 Key Developments
9.2 Bayer AG
9.2.1 Overview
9.2.2 Financial Performance
9.2.3 Product Outlook
9.2.4 Key Developments
9.3 Eli Lilly and Company
9.3.1 Overview
9.3.2 Financial Performance
9.3.3 Product Outlook
9.3.4 Key Developments
9.4 Ferring Pharmaceuticals
9.4.1 Overview
9.4.2 Financial Performance
9.4.3 Product Outlook
9.4.4 Key Developments
9.5 GlaxoSmithKline PLC
9.5.1 Overview
9.5.2 Financial Performance
9.5.3 Product Outlook
9.5.4 Key Developments
9.6 Metuchen Pharmaceuticals LLC
9.6.1 Overview
9.6.2 Financial Performance
9.6.3 Product Outlook
9.6.4 Key Developments
9.7 Pfizer Inc.
9.7.1 Overview
9.7.2 Financial Performance
9.7.3 Product Outlook
9.7.4 Key Developments
9.8 S.K. Chemicals Co. Ltd.
9.8.1 Overview
9.8.2 Financial Performance
9.8.3 Product Outlook
9.8.4 Key Developments
9.9 Teva Pharmaceutical Industries Ltd.
9.9.1 Overview
9.9.2 Financial Performance
9.9.3 Product Outlook
9.9.4 Key Developments
9.10 VIVUS Inc.
9.10.1 Overview
9.10.2 Financial Performance
9.10.3 Product Outlook
9.10.4 Key Developments
10 KEY DEVELOPMENTS
10.1 Product Launches/Developments
10.2 Mergers and Acquisitions
10.3 Business Expansions
10.4 Partnerships and Collaborations
11 Appendix
11.1 Related Research
Report Research Methodology
Verified Market Research uses the latest researching tools to offer accurate data insights. Our experts deliver the best research reports that have revenue generating recommendations. Analysts carry out extensive research using both top-down and bottom up methods. This helps in exploring the market from different dimensions.
This additionally supports the market researchers in segmenting different segments of the market for analysing them individually.
We appoint data triangulation strategies to explore different areas of the market. This way, we ensure that all our clients get reliable insights associated with the market. Different elements of research methodology appointed by our experts include:
Exploratory data mining
Market is filled with data. All the data is collected in raw format that undergoes a strict filtering system to ensure that only the required data is left behind. The leftover data is properly validated and its authenticity (of source) is checked before using it further. We also collect and mix the data from our previous market research reports.
All the previous reports are stored in our large in-house data repository. Also, the experts gather reliable information from the paid databases.
For understanding the entire market landscape, we need to get details about the past and ongoing trends also. To achieve this, we collect data from different members of the market (distributors and suppliers) along with government websites.
Last piece of the ‘market research’ puzzle is done by going through the data collected from questionnaires, journals and surveys. VMR analysts also give emphasis to different industry dynamics such as market drivers, restraints and monetary trends. As a result, the final set of collected data is a combination of different forms of raw statistics. All of this data is carved into usable information by putting it through authentication procedures and by using best in-class cross-validation techniques.
Data Collection Matrix
| Perspective | Primary Research | Secondary Research |
|---|---|---|
| Supplier side |
|
|
| Demand side |
|
|
Econometrics and data visualization model
Our analysts offer market evaluations and forecasts using the industry-first simulation models. They utilize the BI-enabled dashboard to deliver real-time market statistics. With the help of embedded analytics, the clients can get details associated with brand analysis. They can also use the online reporting software to understand the different key performance indicators.
All the research models are customized to the prerequisites shared by the global clients.
The collected data includes market dynamics, technology landscape, application development and pricing trends. All of this is fed to the research model which then churns out the relevant data for market study.
Our market research experts offer both short-term (econometric models) and long-term analysis (technology market model) of the market in the same report. This way, the clients can achieve all their goals along with jumping on the emerging opportunities. Technological advancements, new product launches and money flow of the market is compared in different cases to showcase their impacts over the forecasted period.
Analysts use correlation, regression and time series analysis to deliver reliable business insights. Our experienced team of professionals diffuse the technology landscape, regulatory frameworks, economic outlook and business principles to share the details of external factors on the market under investigation.
Different demographics are analyzed individually to give appropriate details about the market. After this, all the region-wise data is joined together to serve the clients with glo-cal perspective. We ensure that all the data is accurate and all the actionable recommendations can be achieved in record time. We work with our clients in every step of the work, from exploring the market to implementing business plans. We largely focus on the following parameters for forecasting about the market under lens:
- Market drivers and restraints, along with their current and expected impact
- Raw material scenario and supply v/s price trends
- Regulatory scenario and expected developments
- Current capacity and expected capacity additions up to 2027
We assign different weights to the above parameters. This way, we are empowered to quantify their impact on the market’s momentum. Further, it helps us in delivering the evidence related to market growth rates.
Primary validation
The last step of the report making revolves around forecasting of the market. Exhaustive interviews of the industry experts and decision makers of the esteemed organizations are taken to validate the findings of our experts.
The assumptions that are made to obtain the statistics and data elements are cross-checked by interviewing managers over F2F discussions as well as over phone calls.
Different members of the market’s value chain such as suppliers, distributors, vendors and end consumers are also approached to deliver an unbiased market picture. All the interviews are conducted across the globe. There is no language barrier due to our experienced and multi-lingual team of professionals. Interviews have the capability to offer critical insights about the market. Current business scenarios and future market expectations escalate the quality of our five-star rated market research reports. Our highly trained team use the primary research with Key Industry Participants (KIPs) for validating the market forecasts:
- Established market players
- Raw data suppliers
- Network participants such as distributors
- End consumers
The aims of doing primary research are:
- Verifying the collected data in terms of accuracy and reliability.
- To understand the ongoing market trends and to foresee the future market growth patterns.
Industry Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|---|---|
|
|
